The converging on cancer seminar series is back and this time we are hosting a special seminar on Thursday 15th September, from 15.00-16.00, exploring how we can support the translation of your research with the help of Dissemination and Implementation science. Please join us to hear from Dr Patrick Kierkegaard (CRUK Convergence Science Centre), Dr Melody Zhifang Ni (NIHR London-IVD), and Dr Emma Harris (The Institute of Cancer Research).
Dr Melody Zhifang Ni– NIHR London-IVD, Department of Surgery and Cancer, Imperial College London
“One-stop shop evidence generation at NIHR London IVD to support medtech translation”
Evidence is key to translate innovative ideas throughout the product lifecycle. Since 2013, NIHR London IVD has been working with patient representatives, developers, innovators, regulators and healthcare providers etc to gain an understanding of what such evidence looks like, and how such evidence could enable truly beneficial technologies to be developed and implemented in healthcare. This short presentation will briefly outline the range of tools LIVD has developed including POCKET (point of care key evidence checklist), LAMP (lean and agile multi-attribute process) and the Biomarker toolkit.
&
Dr Patrick Kierkegaard– CRUK Convergence Science Centre
“Define, De-risk and Develop: How the Convergence Centre can help you create a value for your innovation and de-risk translational challenges from an early-stage”
Having a good idea and developing a cutting-edge innovation is not enough to get it translated into the real-world. You need to present it to the world and convince people, funders, regulators, and the NHS that your innovation will bring value to them. The CRUK Convergence Centre has the research infrastructure to support clinicians and scientists in this process. In this talk, I will present an overview of how the Convergence Centre applies Human Factors and Implementation Science methodologies to support clinicians & scientists create value for their innovation.
&
Dr Emma Harris– Division of Radiotherapy & Imaging, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
“Clinical implementation of elastography to monitor the treatment response of cancer to radiation therapy”
My group has developed a novel ultrasound technique, vibrational shear wave elastography (VSWE, to probe the biomechanical properties of tumours which may be used to assess tumour response. The next step is to design a clinical system for test in human subjects. This talk will discuss how Patrick Kierkegaard is helping us to gain crucial understanding of the exact clinical needs, any practical or perceptual barriers to implementation, and the potential impact and costs of VSWE, information essential to inform the system design and optimise the success of initial clinical studies.
Registration
To receive information about how to access this event please email icr-imperial-convergence.centre@imperial.ac.uk
Please note: This webinar is exclusively available only to colleagues across the Institute of Cancer Research, Imperial College London, the Royal Marsden Hospital and Imperial College Healthcare.